News

ORNL researcher Louise Evans is working to ensure safeguards approaches and verification technologies are integrated early in the design process of advanced reactor technologies. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Decades of nuclear expertise guides global nonproliferation innovation
To turn carbon dioxide, or CO2, into methanol, or CH3OH, copper (shown in yellow) on a hydride-substituted support speeds reactions mediated by hydrides and catalyzed by hydrogen atoms (shown in black) from surface-adsorbed formate, HCOO*. Credit: Yang He/ORNL, U.S. Dept. of Energy
Ion swap improves CO2-defeating catalyst
Caption: The Na-CO2 battery developed at ORNL, consisting of two electrodes in a saltwater solution, pulls atmospheric carbon dioxide into its electrochemical reaction, and releases only valuable biproducts. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy
Carbon-capture batteries store renewable energy

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

Jason Gardner, Sandra Davern and Peter Thornton have been elected fellows of AAAS. Credit: Laddy Fields/ORNL, U.S. Dept. of Energy

AAAS elects three ORNL scientists as fellows

Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.

Mars Rover 2020

Secretary’s Honor Awards recognize dozens of ORNL employees

More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

DOE scientists deploy creativity, speed to disrupt COVID-19

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.